Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified?

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 2, 1999, Pages 756-760

  Hegedüs, Laszlo ^b   Nygaard, Birte ^a   Hansen, Jens Mølholm ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG EFFECT; FEMALE; GOITER; HORMONAL REGULATION; HUMAN; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; THYROID DISEASE; THYROID FUNCTION; THYROIDECTOMY;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; GOITER; HUMANS; MALE; MIDDLE AGED; RECURRENCE; THYROIDECTOMY; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0033051939     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.2.756     Document Type: Article

References (33)

1. 1. Thyroxine replacement therapy - too much of a good thing. Editorial. 1990 Lancet. 336:1352-1353.
2. 2. Burman KD. 1990 Is long-term levothyroxine therapy safe? Arch Intern Med. 150:2010-2013.
3. 3. Toft AD. 1991 Thyroxine replacement therapy. Clin Endocrinol (Oxf). 34:103-105.
4. 4. Mandel SJ, Brent GA, Larsen PR. 1993 Levothyroxine therapy in patients with thyroid disease. Ann Intern Med. 119:492-502.
5. 5. Toft AD. 1994 Thyroxine therapy. N Engl J Med. 331:174-180.
6. 6. Faber J, Galloøe AM. 1994 Changes in bone mass during prolonged subdinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol. 130:350-356.
7. 7. Perrild H, Hansen JM, Hegedüs L, et al. 1982 Triiodothyronine and thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic scanning. Acta Endocrinol (Copenh). 100:382-387.
8. 8. Persson CP, Johansson H, Westermark K, Karlsson FA. 1982 Nodular goitre - is thyroxine medication of any value? World J Surg. 6:391-396.
9. 9. Geerdsen JP, Frølund L. 1984 Recurrence of non-toxic goitre with and without postoperative thyroxine medication. Clin Endocrinol (Oxf). 21:529-533.
10. 10. Westermark K, Persson PA, Johansson H, Karlsson AF. 1986 Nodular goiter: effects of surgery and thyroxine medication. World J Surg. 10:481-487.
11. 11. Berghout A, Wiersinga WM, Drexhage HA, et al. 1989 The long-term outcome of thyroidectomy for sporadic non-toxic goitre. Clin Endocrinol (Oxf). 31:193-199.
12. 12. Berglund J, Bondesson L, Christensen SB, Larsson AS, Tibblin S. 1990 Indications for thyroxine therapy after surgery for non-toxic benign goitre. Acta Chir Scand. 156:433-438.
13. 13. Bistrup C, Nielsen JD, Gregersen G, Franch P. 1994 Preventive effect of levothyroxine in patients operated for non-toxic goitre: a randomized trial of one hundred patients with nine years follow-up. Clin Endocrinol (Oxf). 40:323-327.
14. 14. Hegedüs L, Hansen JM, Veiergang D, Karstrup S. 1987 Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size? Br Med J. 294:801-803.
15. 15. Hegedüs L, Perrild H, Poulsen LR, et al. 1983 The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab. 56:260-263.
16. 16. Diem K, Lentner C. 1975 Documenta Geigy, scientific tables.
17. 17. Hansen JM, Skovsted L, Siersbæk-Nielsen. 1975 Age dependent changes in iodine metabolism and thyroid function. Acta Endocrinol (Copenh). 79:60-65.
18. 18. Hegedüs L, Karstrup S, Rasmussen N. 1986 Evidence of cyclic alterations of thyroid size during the menstrual cycle in healthy women. Am J Obstet Gynecol. 155:142-145.
19. 19. Hollander K, Wolfe DA. 1973 Non-parametric statistical methods. New York: Wiley; 147-150:37.
20. 20. Andersen PE, Hurley PR, Rosswick P. 1990 Conservative treatment and long-term prophylactic thyroxine in the prevention of recurrence of multinodular goitre. Surg Gynecol Obstet. 171:309-314.
21. 21. Ibis E, Erbay G, Aras G, Akin A. 1991 Postoperative goitre recurrence rate in Turkey. Acta Endocrinol (Copenh). 125:33-37.
22. 22. Miccoli P, Antonelli A, Iacconi P, Alberti B, Gambuzza C, Baschieri L. 1993 Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: result at the third year of follow-up. Surgery. 114:1097-1102.
23. 23. Hegedüs L, Hansen JM. 1991 Thyroxine replacement therapy. Lancet. 337:171-172.
24. 24. Bergfelt G, Risholm L. 1963 Postoperative thyroid hormone therapy in non-toxic goitre. Acta Chir Scand. 126:531-537.
25. 25. Jarlov AE, Nygaard B, Hegedüs L, Hartling SG, Hansen JM. 1998 Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter. Thyroid. 8:393-398.
26. 26. Papini E, Petrucci L, Guglielmi R, et al. 1998 Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab. 83:780-783.
27. 27. Bennedbæk FN, Nielsen LK, Hegedüs L. 1998 Effect of percutaneous ethanol injection therapy vs. suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial. J Clin Endocrinol Metab. 83:830-835.
28. 28. Nygaard B, Hegedüs L, Gervil M, Hjalgrim H, Søe-Jensen P, Hansen JM. 1993 Radioiodine treatment of multinodular non-toxic goitre. Br Med J. 307:828-832.
29. 29. Ross DS. 1991 Monitoring L-thyroxine therapy: lessons from the effects of L-thyroxine on bone density. Am J Med. 91:1-4.
30. 30. Petersen K, Bengtsson C, Lapidus L, Lindstedt G, Nystrøm E. 1990 Morbidity, mortality, and quality of life for patients treated with levothyroxine. Arch Intern Med. 50:2077-2081.
31. 31. Gärtner R, Greil W, Demharter R, Horn K. 1985 Involvement of cyclic AMP, iodide and metabolites of arachidonic acid in the regulation of cell proliferation of isolated porcine thyroid follicles. Mol Cell Endocrinol. 42:145-155.
32. 32. Zeki K, Azuma H, Suzuki H, Morimoto I, Eto S. 1991 Effects of interleukin 1 on growth and adenosine 3', 5'-monophosphate generation of the rat thyroid cell line, FRTL-5 cells. Acta Endocrinol (Copenh). 124:60-66.
33. 33. Drexhage HA, Bottazzo GF, Doniach D. 1980 Evidence for thyroid-growth-stimulating immunoglobulins in some goitrous thyroid diseases. Lancet. 1:287-292.